India expected to have Covid vaccine from more than one source by early next year: Health minister

Nine vaccine candidates are in an advanced clinical trial stage, of which three are in India, Harsh Vardhan said.

India is expected to have a Covid-19 vaccine from more than one source by early next year and the government is formulating distribution strategies for the immunisation of people across the country, Union Health Minister Harsh Vardhan said on Tuesday.

“We’re expecting that early next year we should have vaccine in the country from more than one source. We are formulating strategies for planned distribution of the vaccine in the country,” he said in a tweet after chairing the 21st meeting of the High-level Group of Ministers (GoM) on Covid-19 through video-conference.

#GoM Meeting

We’re expecting that early next year we should have vaccine in the country from maybe more than one source.

We are formulating strategies for planned distribution of the vaccine in the country.@MoHFW_INDIA @PMOIndia #COVID19 pic.twitter.com/w5H5lqdh9f

— Dr Harsh Vardhan (@drharshvardhan) October 13, 2020

Vardhan had earlier said a Covid-19 vaccine is likely to be available by the first quarter of 2021. He had also said the Centre estimates to receive and utilise 40-50 crore doses of a Covid-19 vaccine, covering 20-25 crore people, by July next year.

On Sunday, the minister said considering the large population size of India, one vaccine or vaccine manufacturer will not be able to fulfil the requirements of vaccinating the entire country and added that the government is open to assessing the feasibility of introducing several Covid-19 vaccines in the country in accordance with their availability.

Vardhan further said the country’s preparedness to make a Covid-19 vaccine available to its citizens was reviewed at the GoM meet.

He added that work is going on around 200 vaccine candidates across the world, of which 151 are in pre-clinical stages and about 40-42 are in various clinical trial stages. Nine vaccine candidates are in an advanced clinical trial stage, of which three are in India.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest India News, download Indian Express App.